Company Overview and News

29
U.S. IPO Week Ahead: Tech, Tech, And More Tech With 11 U.S. IPOs Planned For This Coming Week

1h seekingalpha
11 IPOs are expected to price this week, making it another busy one, and totaling $3.4 billion in combined proceeds. A whopping six tech deals are pricing, including three from China. Chinese e-commerce giant Pinduoduo is the week's largest deal, raising $1.5 billion. US cybersecurity play Tenable should get the most attention - almost every enterprise software IPO with its profile has been a homerun.
DB BRY MS.PRE MS.PRF MS.PRG MS.PRA IPO MS.PRI SPOT MS.PRK MS IPOS SNAP

0
Idiosyncratic Small-Cap Stocks: How To Manage Volatility

5h seekingalpha
A fundamental reason people invest in small caps is their potential for better returns over longer periods. Small caps as an asset class tend to be more growth oriented, and thus investors may stand to gain more from allocating to small caps. However, higher volatility is inherent to U.S. small caps too.
RPUT MS.PRI MS.PRK MS.PRE MS.PRF MS.PRG MS MS.PRA

0
Platform Specialty Products Corp (PAH) Announcing Sale of Arysta LifeScience and a New Chapter Confernece Call (Transcript)

16h seekingalpha
Platform Specialty Products Corp (NYSE:PAH) Announcing the Sale of Arysta LifeScience and a New Chapter Conference Call July 20, 2018 8:30 AM ET
MS.PRI PAH MS.PRK MS.PRE MS.PRF MS.PRG MS MS.PRA

1
State Street Corporation (STT) CEO Jay Hooley on Q2 2018 Results - Earnings Call Transcript

18h seekingalpha
Good morning, and welcome to State Street Corporation's Second Quarter of 2018 Earnings Conference Call and Webcast. Today's discussion is being broadcast live on State Street's website at investors.statestreet.com.
STT STT.PRC STT.PRE STT.PRD MS.PRE STT.PRG MS.PRF MS.PRG MS.PRA MS.PRI MS.PRK 3772 MS

0
Faurecia's (FURCF) CEO Patrick Koller on Half Year 2018 Results - Earnings Call Transcript

19h seekingalpha
Welcome to the presentation of our first half 2018 results. I propose to give you the highlights of this first half. Michel Favre will then detail our H1 2018 results, and I will close this presentation with our upgraded guidance.
DB MS.PRI SCGLF MS.PRK MS.PRE MS.PRF SCGLY MS.PRG GLE MS MS.PRA

54
Bank ETFs Rise on the Wave of Big Releases

19h zacks
The financial sector, which accounts for around one-fifth of the S&P 500 index, is now busy with Q2 earnings releases. The going is great so far, with five big banks crushing estimates on both lines and one reporting mixed results. The backdrop should favor the banks along with the course of oil, the stance taken by the Fed and the proposed policies of Trump (read: How Financial ETFs Look After Fed Stress Test).
WFCNP C.WSA MS.PRE WFC.PRL MS.PRF WFC.PRJ MS.PRG MS.PRA BAC WFC.PRT C.WS.B WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP C.PRU WFC.PRY MS WFC.PRX WFC.PRW WFC.PRV C.PRS WFC WFC.WS BAC C VFH C.PRL IYG C.PRJ C.PRK C.PRG C.PRC MS.PRI C.PRPCL MS.PRK CGBBW

0
3 Casino Stocks to Buy Now

20h zacks
Perhaps it is because trading stocks can often mirror the thrill of winning big at the blackjack tables, or maybe it is because Las Vegas conjures images of the world’s most flashy brands and businessmen. Regardless of the reason, it is clear that gambling stocks are always among the most popular on Wall Street.
MS.PRI MS.PRK MS.PRE MS.PRF PENN MS.PRG MS RRR MS.PRA BYD

0
Kansas City Southern (KSU) CEO Patrick Ottensmeyer on Q2 2018 Results - Earnings Call Transcript

20h seekingalpha
Greetings and welcome to the Kansas City Southern Second Quarter 2018 Earnings Call. At this time, all participants will be in a listen-only mode. A brief question-and-answer session will follow the formal presentation.
MS.PRI MS.PRK KSU.PR MS.PRE MS.PRF MS.PRG MS MS.PRA KSU

0
BUZZ-U.S. stocks weekly: Earnings-trade

21h reuters
** S&P 500 ekes out gain of just 0.02 pct as investors grapple with earnings reports and Trump tariff threats
MS.PRI MS.PRK MS.PRE MS.PRF MS.PRG MS MS.PRA

12
Jones Energy, Inc. Appoints New Chief Executive Officer and Announces Changes to the Board of Directors

21h globenewswire
AUSTIN, Texas, July 20, 2018 (GLOBE NEWSWIRE) -- Jones Energy, Inc. (NYSE:JONE) (“Jones Energy” or “the Company”) today announced that its Board of Directors has hired Mr. Carl F. Giesler, Jr. as the Company’s new Chief Executive Officer effective July 23, 2018.
MS.PRI MS.PRK NOA JNEEP MS.PRE MS.PRF MS.PRG MS NOA MS.PRA JONE HRG

5
Audiophiles Preparing For Sonos' Huge Forthcoming IPO

21h seekingalpha
Smart speaker company Sonos is preparing for an IPO, but financial details like the amount of shares offered and expected profits aren't yet known.
MS.PRI GOOGL MS.PRK MS.PRE MS.PRF MS.PRG GOOG MS BBY MS.PRA

0
AUD Vulnerable Against USD Strength

22h seekingalpha
Risks within the Australian housing sector are beginning to surface in an ugly way, potentially forcing the RBA to diverge from its current stance of normalising policy over time.
MS.PRI MS.PRK MS.PRE MS.PRF MS.PRG MS MS.PRA

1
Citizens Financial Group (CFG) CEO Bruce Van Saun on Q2 2018 Results - Earnings Call Transcript

23h seekingalpha
Good morning everyone, and welcome to the Citizens Financial Group Second Quarter 2018 Earnings Conference call. My name is Paul, and I'll be your operator today. [Operator Instructions] As a reminder, this event is being recorded.
CFG CFIN DB MS.PRI CIWV MS.PRK MS.PRE MS.PRF MS.PRG MS MS.PRA

0
Millicom International Cellular S.A.'s (MIICF) CEO Mauricio Ramos on Q2 2018 Results - Earnings Call Transcript

2018-07-20 seekingalpha
Millicom International Cellular S.A. (OTCPK:MIICF) Q2 2018 Results Earnings Conference Call July 20, 2018 8:00 AM ET
MS.PRI MS.PRK MS.PRE MS.PRF MS.PRG MS MS.PRA

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 61763E207